MoneyWorks4Me

The topline advanced to Rs. 2282.48 millions, up 90.44% for the June 2026 quarter as against Rs. 1198.55 millions during the year-ago period.Net profit for the quarter ended June 2026 increased significantly by 94.63% to Rs. 131.67 millions from Rs. 67.65 millions.The company reported a good operating profit of 327.76 millions compared to 169.91 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2282.48 1198.55 90.44 2282.48 1198.55 90.44 6391.21 4562.68 40.08
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 327.76 169.91 92.90 327.76 169.91 92.90 947.94 550.97 72.05
Interest 86.18 65.32 31.94 86.18 65.32 31.94 392.98 223.77 75.62
PBDT 241.58 104.59 130.98 241.58 104.59 130.98 554.96 327.20 69.61
Depreciation 35.71 14.19 151.66 35.71 14.19 151.66 79.14 44.49 77.88
PBT 205.87 90.40 127.73 205.87 90.40 127.73 475.82 282.71 68.31
TAX 74.20 22.75 226.15 74.20 22.75 226.15 143.75 74.63 92.62
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 131.67 67.65 94.63 131.67 67.65 94.63 332.07 208.08 59.59
Equity 55.13 47.22 16.75 55.13 47.22 16.75 54.73 47.22 15.90
PBIDTM(%) 14.36 14.18 1.29 14.36 14.18 1.29 14.83 12.08 22.83

Fredun Pharma Share Price

1244.20 22.40 (1.83%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: